Tracon Pharmaceuticals, Inc. (TCON)

Oncology Corporate Profile

Stock Performance

7.4400
-0.0300

HQ Location

8910 University Center Lane, Suite 700
San Diego, CA 92122

Company Description

Tracon develops targeted therapies for cancer, AMD and fibrotic diseases. Tracon's current pipeline includes two clinical stage product candidates: TRC105, an anti-endoglin antibody that is being developed for the treatment of renal cell carcinoma, soft tissue sarcoma, hepatocellular carcinoma, glioblastoma and choriocarcinoma, and TRC102, a small molecule that is being developed for the treatment of lung cancer and glioblastoma.

Website: http://www.traconpharma.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
TRC105chimeric monoclonal antibody (inhibits CD105 - humanized)AngiosarcomaIII
TRC105chimeric monoclonal antibody (inhibits CD105 - humanized)Gestational trophoblastic neoplasia (GTNII
TRC102alkylating agent potentiatorGlioblastoma Multiforme (GBM)II
TRC105chimeric monoclonal antibody (inhibits CD105 - humanized)Hepatocellular carcinoma (HCC)II
TRC102alkylating agent potentiatorMesotheliomaII
TRC105chimeric monoclonal antibody (inhibits CD105 - humanized)Renal cell carcinoma (RCC)II
TRC105chimeric monoclonal antibody (inhibits CD105 - humanized)Breast cancerI
TRC105chimeric monoclonal antibody (inhibits CD105 - humanized)Non Small Cell Lung Cancer (NSCLC)I
TRC102alkylating agent potentiatorNon Small Cell Lung Cancer (NSCLC)I
TRC102alkylating agent potentiatorVarious cancer typesI
TRC694NIK inhibitorMultiple MyelomaPreclinical

View additional information on product candidates here »

Source: http://www.traconpharma.com

Recent News Headlines

5/27/2017 06:19 am

5/27/2017 06:19 am

5/27/2017 06:19 am

5/27/2017 06:19 am

5/25/2017 12:19 pm

5/25/2017 12:19 pm

5/25/2017 12:19 pm

5/25/2017 12:19 pm

5/24/2017 06:19 am

5/24/2017 06:19 am

5/24/2017 06:19 am

5/24/2017 06:19 am

5/11/2017 12:19 pm

5/10/2017 12:19 pm

5/10/2017 12:19 pm

5/10/2017 06:19 am

5/10/2017 06:19 am

5/10/2017 06:19 am

5/3/2017 12:19 pm

5/3/2017 12:19 pm

4/10/2017 12:17 pm

TRACON Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference

3/29/2017 08:00 pm

[GlobeNewswire] - SAN DIEGO, March 29, 2017-- TRACON Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related ...

TRACON Pharmaceuticals Announces TRC694 Data Presentation at Upcoming AACR Annual Meeting

3/27/2017 08:00 pm

[GlobeNewswire] - SAN DIEGO, March 27, 2017-- TRACON Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related ...